Solazyme Appoints Ian Clark and Ann Mather to Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Solazyme, a renewable oil company and leader in industrial biotechnology, announced today that the company has expanded its board of directors with the addition of Ian Clark, current CEO of Genentech, and Ann Mather, former Chief Financial Officer of Pixar Studios, and current board member at companies including Google, Netflix and MGM Holdings, Inc.

Solazyme Chief Executive Officer and Co-founder, Jonathan Wolfson, commented: “Both Ian and Ann bring strong leadership and valuable business experience to the board at Solazyme. We are excited to welcome their insight to our board as we continue to grow and mature.”

Ian Clark

Ian Clark is Chief Executive Officer, Genentech, a member of the Roche Group and head of North American Commercial Operations. He joined Genentech in 2003 as senior vice president and general manager, BioOncology and, in January 2006, was named executive vice president, Commercial Operations and became a member of the Executive Committee. Prior to joining Genentech, Mr. Clark served as president of Novartis Canada, overseeing all of the company’s country operations. His previous board experience includes Vernalis and Dendreon both publicly traded biopharmaceutical companies. Mr Clark is also on the Board of the BIO Industry Association and an Advisor to the Institute of Life Sciences at Southampton University in the UK.

Ann Mather

Ann Mather is lead director at MGM Holdings Inc., a motion picture and television production and distribution company. She is also a member of the board at Google, where she serves as chair of the Audit Committee, and is a director at Netflix, Glu Mobile Inc., and MoneyGram International. Ms. Mather was formerly Chief Financial Officer at Pixar Studios and prior to that held senior roles at the Walt Disney Company.

About Solazyme:

Solazyme, Inc. is a renewable oil company and a leader in industrial biotechnology. Founded in 2003 and headquartered in South San Francisco, Solazyme’s proprietary technology transforms a range of low-cost plant-based sugars into high-value oils. Our renewable products can replace or enhance oils derived from the world’s three existing sources—petroleum, plant and animal fats. We tailor the composition of our oils to address specific customer requirements, offering superior performance characteristics at a competitive cost to conventional oils. Solazyme's oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure. Solazyme's investors, among others, include Braemar Energy Ventures, Harris & Harris Group, Lightspeed VenturePartners, The Roda Group, VantagePoint Venture Partners, and Zygote Ventures.



CONTACT:

Solazyme
Genet Garamendi
press@solazyme.com
Or
The OutCast Agency
John O'Brien, 415-345-4721
Solazyme@theoutcastagency.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:   Energy  Alternative Energy  Health  Biotechnology  Environment

MEDIA:

Logo Image removed.
Read more on